KIT-Alzheimer

Sistemas de detección y cuantificación de biomarcadores de la enfermedad de Alzheimer (KIT-Alzheimer)


The principal objective of the KIT-Alzheimer project is the development of a device for the early detection of the Alzheimer disease, while at the same time monitoring potential therapies for the disease. The project will use the ultimate developments in the field of nanomedicine, in the hope of constructing an in vitro diagnostic device, easily installable at the doctor’s office, dispensary or neurological ward, as well as other work locations.

The use of biosensors is one of the systems for detection of biomarkers, orientated to medical diagnosis which will mark the future of clinical practice, not only at a diagnosis level but also in the personalization of the therapies to apply to the disease. Following this line, the group IMB-CSIC and NB4D-CIBER-BBN have developed a device that presents higher sensitivity characteristics and that has demonstrated its potential in detecting and selectively quantifying biomarkers and other chemical compounds in the sample to be tested. The KIT-Alzheimer project will be the first implementation of this sensory system for a clinical problem and can later be expanded to many other cases when applied to the appropriate biomarker.
Partners
  • IMB-CNM-CSIC
  • FAE
  • Thrombotargets Europe
  • University of Barcelona

Participating Investigators
Funding
MICINN, Subdirección General de Estrategias de Colaboración Público-Privada
IPT-2011-1055-900000

Duration: 2011 - 2014
©   NANOBIOTECHNOLOGY for DIAGNOSTICS 
www.nb4diagnostics.org - nb4d@iqac.csic.es
Sitemap - Legal Advice Design by: